I et klinisk forsøg svarede symptomerne på hypoglykæmi eller modreguleret hormonrespons efter intravenøs insulin glargin til humant insulin givet til både raske forsøgspersoner og type 1- diabetikere.
18 In a clinical study, symptoms of hypoglycaemia or counter-regulatory hormone responses were similar after intravenous insulin glargine and human insulin both in healthy volunteers and patients with type 1 diabetes.